Cargando…
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
BACKGROUND: In drug development, it is important to have an understanding of the full spectrum of co-morbidities to be expected in the group of patients with the disease of interest. It is usually a challenge to identify the less common events associated with the target disease, even if these events...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987972/ https://www.ncbi.nlm.nih.gov/pubmed/20973999 http://dx.doi.org/10.1186/1471-2474-11-247 |